You can buy or sell Evoke Pharma and other stocks, options, ETFs, and crypto commission-free!
Evoke Pharma, Inc. Common Stock, also called Evoke Pharma, is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. Read More It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.
Solana Beach, California
52 Week High
52 Week Low
Evoke Pharma (EVOK) to Post Q1 Earnings: What's in Store?
Investor focus will remain on Evoke Pharma, Inc.'sEVOK progress and issues related to its new drug application (NDA) filling for Gimoti to treat diabetic gastroparesis when i t report s first-quarter 2019 earnings results. The company's performance over the trailing four quarters has been encouraging with its earnings having surpassed expectations twice while missing the same just once and delivering in-line results on another occasion. The average previous four-quarter negative surprise is 3.40%. In the l...
-$0.07 per share
-$0.11 per share